Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.70
-0.05-1.33%
At close: -
$3.70
0.000.00%
After Hours: Jul 18, 8:58 AM EDT
Comments
Loading...
Eledon Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:ELDN | Benzinga
Eledon Pharmaceuticals Inc has a consensus price target of $11 based on the ratings of 4 analysts. The high is $16 issued by HC Wainwright & Co. on November 20, 2024. The low is $9 issued by HC Wainwright & Co. on June 18, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on June 18, 2025, November 20, 2024, and June 4, 2024, respectively. With an average price target of $13.67 between HC Wainwright & Co., there's an implied 269.37% upside for Eledon Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
HC Wainwright & Co.
Noble Capital Markets
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for Eledon Pharmaceuticals
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
06/18/2025 | 143.24% | HC Wainwright & Co. | → $9 | Assumes | → Buy | |||
11/20/2024 | 332.43% | HC Wainwright & Co. | $16 → $16 | Reiterates | Buy → Buy | |||
06/04/2024 | 332.43% | HC Wainwright & Co. | $16 → $16 | Reiterates | Buy → Buy | |||
05/10/2024 | 332.43% | HC Wainwright & Co. | $16 → $16 | Reiterates | Buy → Buy | |||
05/07/2024 | 332.43% | HC Wainwright & Co. | $13 → $16 | Maintains | Buy | |||
03/22/2024 | 251.35% | HC Wainwright & Co. | $13 → $13 | Reiterates | Buy → Buy | |||
11/13/2023 | 251.35% | HC Wainwright & Co. | → $13 | Reiterates | Buy → Buy | |||
10/24/2023 | 251.35% | HC Wainwright & Co. | $25 → $13 | Maintains | Buy | |||
09/27/2023 | 170.27% | Noble Capital Markets | → $10 | Initiates | → Outperform | |||
08/22/2023 | 143.24% | Cantor Fitzgerald | → $9 | Reiterates | Overweight → Overweight | |||
05/26/2023 | 575.68% | HC Wainwright & Co. | → $25 | Reiterates | Buy → Buy |
FAQ
What is the target price for Eledon Pharmaceuticals (ELDN) stock?
The latest price target for Eledon Pharmaceuticals (NASDAQ:ELDN) was reported by HC Wainwright & Co. on June 18, 2025. The analyst firm set a price target for $9.00 expecting ELDN to rise to within 12 months (a possible 143.24% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Eledon Pharmaceuticals (ELDN)?
The latest analyst rating for Eledon Pharmaceuticals (NASDAQ:ELDN) was provided by HC Wainwright & Co., and Eledon Pharmaceuticals their buy rating.
When was the last upgrade for Eledon Pharmaceuticals (ELDN)?
There is no last upgrade for Eledon Pharmaceuticals
When was the last downgrade for Eledon Pharmaceuticals (ELDN)?
There is no last downgrade for Eledon Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Eledon Pharmaceuticals (ELDN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eledon Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eledon Pharmaceuticals was filed on June 18, 2025 so you should expect the next rating to be made available sometime around June 18, 2026.
Is the Analyst Rating Eledon Pharmaceuticals (ELDN) correct?
While ratings are subjective and will change, the latest Eledon Pharmaceuticals (ELDN) rating was a with a price target of $0.00 to $9.00. The current price Eledon Pharmaceuticals (ELDN) is trading at is $3.70, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
